Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - An Action Plan toward Gender Equity in a Department of Medicine, 11/19/2021 8:00:00 AM - 11/19/2024 9:00:00 AM, Participants in Medicine Grand Rounds will be able to identify the most current treatment guidelines, innovations, and standards of practice, and apply them to improve the care of individual patients, promote health and wellness in the population, and achieve clinical quality and safety goals. These educational activities are grounded in principles of health equity, evidence based medicine, inter-professional teamwork, patient-centered care, and respect for human dignity.
Presenter
Eileen E. Reynolds, MD
Associate Professor of Medicine, Harvard Medical School
Chief, Division of General Medicine
Vice Chair for Education
Department of Medicine
Beth Israel Deaconess Medical Center
About our Presenter
Dr. Eileen Reynolds graduated from Harvard College magna cum laude in History and Science, and received her medical degree from Harvard Medical School. She served as a house officer in primary care internal medicine at the University of California, San Francisco, and did fellowship training in General Internal Medicine at the Hospital of the University of Pennsylvania, where she went on to create the Primary Care residency program. She is a former Vice Chair of the ACGME Residency Review Committee in Internal Medicine, and former President of the Society of General Internal Medicine. In addition to her roles as Vice Chair for Education and Chief of the Division of General Internal Medicine, for the past five years, she has chaired the Department of Medicine’s Committee on the Advancement of Women at Beth Israel Deaconess Medical Center.
Learning Outcome(s)
Participants will be able to describe the current state of gender equity in academic medicine and review action steps taken to correct inequities in the academic work space.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Eileen E. Reynolds, MD
Associate Professor of Medicine, Harvard Medical School
Chief, Division of General Medicine
Vice Chair for Education
Department of Medicine
Beth Israel Deaconess Medical Center
About our Presenter
Dr. Eileen Reynolds graduated from Harvard College magna cum laude in History and Science, and received her medical degree from Harvard Medical School. She served as a house officer in primary care internal medicine at the University of California, San Francisco, and did fellowship training in General Internal Medicine at the Hospital of the University of Pennsylvania, where she went on to create the Primary Care residency program. She is a former Vice Chair of the ACGME Residency Review Committee in Internal Medicine, and former President of the Society of General Internal Medicine. In addition to her roles as Vice Chair for Education and Chief of the Division of General Internal Medicine, for the past five years, she has chaired the Department of Medicine’s Committee on the Advancement of Women at Beth Israel Deaconess Medical Center.
Learning Outcome(s)
Participants will be able to describe the current state of gender equity in academic medicine and review action steps taken to correct inequities in the academic work space.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
